Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
about
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@ast
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@en
type
label
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@ast
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@en
prefLabel
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@ast
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Evaluation of a novel rash sca ...... ed non-small cell lung cancer.
@en
P2093
Christine H Chung
David P Carbone
Gail Ratko
Ilyssa O Gordon
Keyoumars Soltani
Kristen E Wroblewski
Livia Szeto
Mario E Lacouture
Mark F Kozloff
Matthew R Levine
P2860
P2888
P356
10.1186/1471-2407-14-5
P407
P577
2014-01-04T00:00:00Z
P5875
P6179
1000283924